Skip to main content

Table 2 Univariate and multivariable analysis using prognostic factors in all of datasets

From: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients

CohortCharacteristicsUnivariate Cox RegressionMultivariate Cox Regression
HR95% CIPHR95% CIP
TCGAScore0.878(0.849,0.908)2.23*10−140.889(0.857,0.922)3.27*10−10
Age1.019(1.008,1.030)0.0011.018(1.007,1.030)0.002
Grade
 110.17310.654
 2 vs 11.254(0.302,5.21)0.7560.814(0.191,3.459)0.78
 3 vs 11.773(0.44,7.138)0.4211.319(0.325,5.358)0.699
Others2.304(0.489,10.866)0.2911.256(0.252,6.25)0.781
Stage
 I-II10.00210.047
 III2.374(1.258,4.479)0.0082.226(1.032,4.802)0.041
 IV3.219(1.633,6.345)0.0012.805(1.241,6.336)0.013
Surgical debulking1.293(0.989,1.691)0.0611.138(0.861,1.504)0.362
TothillScore0.929(0.877,0.985)0.0130.924(0.866,0.985)0.015
Age1.021(1.000,1.042)0.0471.025(1.003,1.047)0.027
Grade
 110.46710.804
 2 vs 11.964(0.549,6.499)0.2691.269(0.374, 4.309)0.703
 3 vs 12.116(0.660,6.791)0.2081.246(0.369,4.200)0.723
Others0.751(0.077,7.287)0.8050.47(0.045,4.868)0.527
Stage
 I-II10.0110.046
 III4.012(1.269,12.685)0.0183.319(1.006,10.950)0.049
 IV6.657(1.906,23.245)0.0035.118(1.377,19.024)0.015
Surgical debulking0.608(0.397,0.932)0.0220.688(0.439,1.079)0.104
TJScore0.841(0.746,0.949)0.0050.862(0.750,0.990)0.036
Age1.048(1.011,1.087)0.0111.050(1.013,1.089)0.008
Grade
 110.94310.693
 2 vs 11.146(0.363,3.622)0.8161.551(0.470,5.126)0.471
 3 vs 11.274(0.496,3.272)0.6151.799(0.638,5.075)0.267
Others1.538(0.296,7.981)0.6082.400(0.408,14.115)0.333
Stage
 I-II10.08710.038
 III3.101(1.063,9.046)0.0383.986(1.282,12.392)0.017
 IV3.661(1.098,12.210)0.0354.956(1.378,17.829)0.014
Surgical debulking0.443(0.225,0.874)0.0190.617(0.298,1.276)0.193